Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

NCT00086502 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Comparator: Sitagliptin
DRUG: Comparator: Placebo
DRUG: Comparator: Pioglitazone
DRUG: Metformin

Sponsor

Merck Sharp & Dohme LLC